Ted White

Insider Reports History

Entity
Individual
Location
C/O Verrica Pharmaceuticals Inc., 10 North High Street, Suite 200, West Chester, PA
Signature
/s/ Mark Ballantyne, Attorney-in-Fact
All insider transactions
Transactions in reports broken out by “transaction date” reported in original SEC filing, see here for transactions aggregated across transaction date

Holdings reported by Ted White:

Stock Role Class Num Shares Value Price $ Report Date Ownership
Verrica Pharmaceuticals Inc. PRESIDENT AND CEO, Director Common Stock 216K $531K $2.46 Aug 27, 2024 Direct
Verrica Pharmaceuticals Inc. PRESIDENT AND CEO, Director Employee Stock Option (right to buy) 225K Mar 15, 2024 Direct

Insider Reports Filed by Ted White

Symbol Company Period Transactions Value $ Form Type Date Filed Role
VRCA Verrica Pharmaceuticals Inc. Aug 26, 2024 2 -$88.6K 4 Aug 28, 2024 PRESIDENT AND CEO, Director
VRCA Verrica Pharmaceuticals Inc. Jul 22, 2024 2 -$230K 4 Jul 23, 2024 PRESIDENT AND CEO, Director
VRCA Verrica Pharmaceuticals Inc. Mar 15, 2024 2 $0 4 Mar 19, 2024 PRESIDENT AND CEO, Director
VRCA Verrica Pharmaceuticals Inc. Nov 14, 2023 2 -$99.2K 4 Nov 16, 2023 President and CEO, Director
VRCA Verrica Pharmaceuticals Inc. Aug 24, 2023 1 $0 4 Aug 28, 2023 President and CEO, Director
VRCA Verrica Pharmaceuticals Inc. Jul 21, 2023 2 -$245K 4 Jul 25, 2023 President and CEO, Director
VRCA Verrica Pharmaceuticals Inc. Mar 1, 2023 1 $0 4 Mar 3, 2023 President and CEO, Director
VRCA Verrica Pharmaceuticals Inc. Jul 5, 2022 1 $15.8K 4/A Feb 21, 2023 President and CEO, Director
VRCA Verrica Pharmaceuticals Inc. Feb 24, 2022 1 $0 4 Feb 25, 2022 President and CEO, Director
VRCA Verrica Pharmaceuticals Inc. Jun 4, 2021 1 $39.8K 4 Jun 7, 2021 President and CEO, Director